Inventor · disambiguated record
Xavier Jean Michel Langlois
Also filed as: LANGLOIS XAVIER JEAN MICHEL
7 granted patents·12 citations·filing 2002–2016
77Inventor score
Technology areasA61P
Files withJANSSEN PHARMACEUTICA NV4ANDRES-GIL JOSE IGNACIO1DE BRUYN MARCEL FRANS LEOPOLD1MACDONALD GREGOR JAMES1
Top patents by PatentIndex Score
7 records- 0175US8791120B2Fast-dissociating dopamine 2 receptor antagonistsMACDONALD GREGOR JAMES·Filed 2008·Granted Jul 29, 2014·2 cites·4 claims
- 0274US8940743B2Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonistsDE BRUYN MARCEL FRANS LEOPOLD·Filed 2006·Granted Jan 27, 2015·3 cites·8 claims
- 0370US9468640B2Piperidin-4-yl-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 18, 2016·1 cites·2 claims
- 0467US7169786B2Isoxazoline derivatives as anti-depressantsANDRES-GIL JOSE IGNACIO·Filed 2002·Granted Jan 30, 2007·6 cites·16 claims
- 0555US9751860B2Piperidin-4YL-pyridazin-3-ylamine derivatives as fast dissociating dopamine 2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Sep 5, 2017·0 cites·15 claims
- 0654US9422296B2Fast-dissociating dopamine 2 receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 23, 2016·0 cites·5 claims
- 0750US9669035B2Combinations comprising PDE 2 inhibitors such as 1-aryl-4-methyl-[1,2,4]triazolo-[4,3-A]]quinoxaline compounds and PDE 10 inhibitors for use in the treatment of neurological of metabolic disordersJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Jun 6, 2017·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Xavier Jean Michel Langlois files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →